Department of Internal Medicine II, Technical University Munich, 81675 Munich, Germany
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In enteric
synaptosomes of the rat, the role of voltage-dependent Ca2+
channels in K+-induced VIP release and nitric oxide (NO)
synthesis was investigated. Basal VIP release was 39 ± 4 pg/mg,
and cofactor-substituted NO synthase activity was 7.0 ± 0.8 fmol · mg1 · min
1.
K+ depolarization (65 mM) stimulated VIP release
Ca2+ dependently (basal, 100%; K+, 172.2 ± 16.2%; P < 0.05, n = 5).
K+-stimulated VIP release was reduced by blockers of the
P-type (
-agatoxin-IVA, 3 × 10
8 M) and N-type
(
-conotoxin-GVIA, 10
6 M) Ca2+ channels by
~50 and 25%, respectively, but not by blockers of the L-type
(isradipine, 10
8 M), Q-type (
-conotoxin-MVIIC,
10
6 M), or T-type (Ni2+, 10
6 M)
Ca2+ channels. In contrast, NO synthesis was suppressed by
-agatoxin-IVA,
-conotoxin-GVIA, and isradipine by ~79, 70, and
70%, respectively, whereas Ni2+ and
-conotoxin-MVIIC
had no effect. These findings are suggestive of a coupling of
depolarization-induced VIP release primarily to the P- and N-type
Ca2+ channels, whereas NO synthesis is presumably dependent
on Ca2+ influx not only via the P- and N- but also via the
L-type Ca2+ channel. In contrast, none of the
Ca2+ channel blockers affected VIP release evoked by
exogenous NO, suggesting that NO induces VIP secretion by a different
mechanism, presumably involving intracellular Ca2+ stores.
synaptosomes; enteric nervous system; vasoactive intestinal polypeptide; voltage-dependent Ca2+ channels; nitric oxide synthase
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
THE ACTIVATION OF
voltage-dependent Ca2+ channels (VDCCs) is a key
regulatory step in the process of excitation-secretion coupling (4, 25). Molecular neurobiology has revealed a diversity of Ca2+ channel subtypes (for review, see Refs.
15 and 22). They are classified according to their
1-subunit, which is encoded by seven different genes,
and subdivided into classes A (P/Q-type), B (N-type), C and D (L-type),
S (L-type), G (T-type) and E (R-type) Ca2+ channels
(15). Cumulative evidence has been presented that multiple
VDCCs may coexist in a single synapse to regulate neurosecretion from
peripheral autonomic (31) and enteric nerves (37,
41, 43). Immunohistochemistry revealed
1B and
1A channel-like immunoreactivity in nerve processes
within the myenteric plexus of the rat small intestine, suggesting the
presence of N- and P-type Ca2+ channels, respectively
(26). This pattern of distribution closely resembles the
localization of both channels in the central nervous system (34,
38). An
1C immunoreactivity, implying the
presence of L-type Ca2+ channels, appeared to be more
confined to ganglionic structures than to nerve processes
(26). Furthermore, binding sites for both
-conotoxin-GVIA (
-Ctx GVIA), a blocker of the N-type
Ca2+ channel, and nitrendipine, a blocker of the L-type
channel, had been demonstrated on isolated synaptosomes of the canine
small intestine (1), suggesting a role of both channel
types in neurosecretion. However, the functional relevance of these
findings remains to be elucidated.
VIP represents an inhibitory nonadrenergic, noncholinergic (NANC)
neurotransmitter in the gastrointestinal tract that acts in concert
with nitric oxide (NO) to relax smooth muscle. Both VIP and the
NO-synthesizing enzyme neuronal NO synthase (nNOS) are
colocalized in a subset of descending inhibitory neurons in the rat
(2, 17). Previously, it has been shown that enteric synaptosomes release VIP in response to exogenous NO and in a Ca2+-dependent manner following stimulation with KCl
(3) and that a constitutive Ca2+-dependent NOS
activity is retained within isolated nerve terminals from rat small
intestine (23), which is functionally coupled to VIP
release (29). VIP output from longitudinal muscle
preparations with adherent myenteric plexus (LM/MP) has been shown to
be reduced by -Ctx GVIA, a blocker of the N-type Ca2+
channel (11, 13). Since NO is known to relax smooth muscle directly or indirectly by releasing VIP (3, 21), and since the effect of NO on smooth muscle is antagonized in the presence of
-Ctx GVIA (6, 11, 13), it was of interest to
investigate the effect VDCC blockers on NO-induced VIP release as well.
Furthermore, it must be clarified whether selective blockade of VDCCs
other than the N-type channel elicits an effect on VIP release or NO synthesis.
On the ultrastructural level, NOS appears not to be located in the same domain of Ca2+ entry as the VIP-containing vesicles (5), leaving the possibility that both transmitters are controlled independently. So far, no data have been presented regarding the involvement of distinct Ca2+ channels in both the release of VIP from and the control of NO synthesis within nerve terminals.
The aim of the present study was 1) to identify the types of
Ca2+ channels regulating the release of VIP from enteric
nerve terminals by studying Ca2+ channel blockers targeting
subsets of N-type (-Ctx GVIA), L-type (isradipine), T-type
(Ni2+), and P/Q-type [
-agatoxin-IVA (
-Agatx IVA) and
-conotoxin-MVIIC (
-Ctx MVIIC)] Ca2+ channels and
2) to study the effect of the respective Ca2+
channel blockers on NO production by nNOS. These questions have been
addressed (28) by studying isolated nerve terminals that offer the unique opportunity to examine intracellular and subcellular mechanisms of neurotransmitter release without the interference of
other local or systemic factors present in vivo or in the intact organ
in vitro.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Preparative Techniques
Tissue handling and membrane preparation. Synaptosomes were prepared as described previously (28). Briefly, five male Wistar rats were killed by cervical dislocation, and the small intestine was quickly removed and suspended in ice-cold buffer (20 mM MOPS, 10 mM MgCl2, 8% wt/vol sucrose, pH 7.4). All further preparative steps were carried out at 0-4°C. Approximately 6- to 8-cm pieces of small intestine were dissected, cleaned of mesenteric arcade and fat, and opened along the mesenteric attachment line. The mucosal layer was scraped off with a sharp razor blade, and the remaining muscle layers were put into cold buffer. The muscle tissue was blotted dry on filter paper and weighed. For membrane preparation, the tissue was resuspended in isolation buffer (8% wt/vol sucrose, 20 mM MOPS, pH 7.4), minced with scissors, and homogenized with a Polytron PT20 homogenizer at ~1,500 rpm setting for 15 s (3 × 5 s).
Fractionation of tissue homogenate by differential centrifugation. The tissue homogenate was centrifuged in two steps of 800 g for 10 min to remove myofibrils and remaining nuclei. The supernatant was collected [postnuclear supernatant (PNS)] and recentrifuged at 3,500 g for 10 min to obtain the P1 fraction. The supernatant was centrifuged again at 100,000 g for 90 min. The pellet from this centrifugation [microsomal 1 (MIC1)] was resuspended and centrifuged again at 10,000 g for 10 min. The resulting pellet and the supernatant are referred to as mitochondrial 2 (P2) and microsomal 2 (MIC2) fractions, respectively.
Differential centrifugation led to a substantial enrichment of [3H]saxitoxin in the fraction P2 [8-fold (44.9 ± 8 fmol/mg protein) vs. PNS (5.5 ± 1.7 fmol/mg protein)] and was paralleled by a 7.2-fold increase in the content of VIP in the P2 fraction (6.4 ± 1.9 vs. 0.9 ± 0.3 pmol/mg protein in PNS), as reported previously (3). With respect to the methodical approach employed, the synaptosomal fraction consists of a mixed population of nerve terminals, including nerve endings of motoneurons, from different animals.Analytic Techniques
Protein assay.
Protein was measured spectrophotometrically according to the method of
Bradford (8). Bovine serum -globulin was used as standard.
Radioimmunoassay. VIP immunoreactivity was determined as described elsewhere (35). The porcine VIP antibody (provided by S. R. Bloom, Royal Postgraduate Medical School, London, UK) showed no interaction with NH2-terminal fragments of VIP, secretin, peptide histidine isoleucine, growth hormone-releasing factor, gastric inhibitory peptide, or pituitary adenylate cyclase-activating peptide (personal communication, S. R. Bloom). 125I-VIP for the preparation of the labeled VIP and synthetic VIP as standard were purchased from Amersham and Sigma (Munich, Germany), respectively.
Peptide release.
Peptide release studies were carried out in Krebs-Ringer-bicarbonate
solution (KRS; in mM: 115.5 NaCl, 1.16 MgSO4, 1.16 NaH2PO4, 11.1 glucose, 21.9 NaHCO3,
2.5 CaCl2, 4.16 KCl) gassed with 95% O2-5%
CO2. In experiments designed to study the role of
Ca2+-free medium, CaCl2 was omitted and 0.5 mM
EGTA was added. KRS (1,050 µl) and 150 µl of drugs or KRS alone
serving as a control (basal level) were incubated in separate test
tubes at 37°C in a gently shaking water bath. The reaction was
started by adding 300 µl of synaptosomal membranes (300 µg protein)
to each tube at timed intervals. To study the time course of
Ca2+ channel blockade, the blockers were incubated with the
synaptosomes for 0, 5, 15, and 20 min. According to the data obtained
from the time-course experiments, the incubation for all subsequent experiments lasted 15 min. To stop the reaction, the synaptosomal membranes were put on ice and immediately sedimented by high-speed centrifugation in a refrigerated centrifuge. The supernatant was withdrawn and immediately frozen at 20°C until peptide
determination by radioimmunoassay.
Assay of NOS activity. NOS activity was determined by monitoring the formation of L-citrulline from L-arginine by a modification of methods described previously (9). Enzymatic reactions were conducted at 37°C in 25 mM MOPS-8% sucrose buffer containing 1 mM NADPH, 0.1 µM tetrahydrobiopterin, 1 µM calmodulin, 1 mM CaCl2, 0.1 µM FAD, 0.1 µM flavin mononucleotide (FMN), and other test agents as specified later, in a final incubation volume of 750 µl. The L-[3H]arginine was purified by anionic exchange chromatography on columns of Dowex 1×8, OH-form to remove traces of L-[3H]citrulline. After preincubation for 30 min at 4°C with synaptosomes (500 µl), the enzymatic reactions were started by adding ~500,000 dpm of L-[3H]arginine (63 Ci/mmol) and terminated after 15 min by immediate heating to 90°C for 6 min and addition of 1 ml distilled water containing 1 mM L-arginine and 1 mM L-citrulline. Samples were applied to columns containing 1 ml of Dowex AG 50 W × 8 resin, Na+ form, preequilibrated with sucrose MOPS buffer. The eluate (2 ml) was collected in a liquid scintillation vial. After the addition of 1.5 ml scintillation fluid, samples were counted in a Beckman LS 3801 spectrometer. The recovery of L-[3H]citrulline in the first 4 ml of the eluate was ~92%; contamination with L-[3H]arginine did not exceed 2%. Basal values were obtained by heating samples to 100°C for 5 min before incubation. Cofactor-stimulated NOS activity over basal was considered as control. To study the effect of Ca2+-free medium, CaCl2 was omitted and 0.5 mM EGTA was added.
Drugs
The labeled L-[3H]arginine (63 Ci/mmol) was purchased from Amersham. All other reagents were purchased from the indicated sources as follows: NADPH, FAD, FMN, citrulline, calmodulin, pepstatin A, dithiothreitol, trypsin inhibitor, Ni-sulfate, glutamate, carbachol, atropine, [D-penicillamine(2,5)]enkephalin (DPDPE), substance P, and naloxone hydrochloride dihydrate were from Sigma; tetrahydrobiopterin was from ICN Biomedicals (Eschwege, Germany); S-nitroso-N-acetylpenicillamine (SNAP) and N-methyl-D-aspartate (NMDA) were from Calbiochem (Bad Soden, Germany); thiorphan was from Fluka (Munich, Germany); R-4-carboxy-3-hydroxyphenylglycine, 1-aminocyclobutanecarboxylic acid (ACBC), and endomorphin-1 were from Tocris-Cookson Biotrend Chemikalien (Cologne, Germany); [D-Lys(nicotinoyl)1,Statistics
Data are given as means ± SE; n indicates the number of independent observations in separate experiments from separate preparations. For each value of a given drug of a single preparation, the release study was carried out in duplicate. The values of peptide release experiments showed some variation in separate experiments and were therefore expressed as the relative increase over basal levels (=100%). Analysis of variance, followed by Dunnett's post hoc test for multiple testings, was used to determine statistical significance. For comparisons of two means, paired or unpaired t-test was performed. Values of P ![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Assessment of VIP Release From Isolated Synaptosomes
Synaptosomes of rat small intestine are capable of releasing VIP in response to K+ depolarization. Depolarization-induced VIP release occurred in a Ca2+-dependent manner (Fig. 1). Basal release was also significantly reduced (
|
|
Effect of Subtype-Specific Ca2+ Channel Blockers on K+-Induced VIP Release
The sensitivity of K+-evoked release to Ca2+ channel blockade was studied. A first set of experiments was conducted to inquire about the time course of Ca2+ channel blockade by the blockers of the N-, P-, and L-type channels,
|
In a second series of experiments using the 15-min incubation time,
K+ depolarization-induced VIP release was significantly
reduced by ~25 and 50% in the presence of the N- and P-type channel
blockers, -Ctx GVIA and
-Agatx IVA, respectively [basal,
183.1 ± 3.3 pg/mg (100%); K+, 168.6 ± 7.2%;
K+ + 10
6 M
-Ctx GVIA, 152.0 ± 5.4% (P < 0.05; n = 5);
K+ + 3 × 10
8 M
-Agatx IVA,
135.2 ± 13.1% (P < 0.05, n = 5); Fig. 4], suggesting that both
channels are coupled to VIP release evoked by K+. The
combination of both blockers resulted in a further inhibition (10
6 M
-Ctx GVIA + 3 × 10
8 M
-Agatx IVA, 119.6 ± 15.7%; n = 5), which was
not significantly different from that of
-Agatx IVA alone.
|
The Q-type channel blocker -Ctx MVIIC had no significant effect
[basal, 183.1 ± 3.3 pg/mg (100%); K+, 168.6 ± 12.2%; K+ + 10
6 M
-Ctx MVIIC,
163.8 ± 17.5%; n = 5]. The L-type
Ca2+ channel blocker isradipine (10
8M) did
not suppress K+-evoked VIP release, nor did it augment the
inhibition in the presence of
-Ctx GVIA and
-Agatx IVA [basal,
183.1 ± 3.3 pg/mg (100%); K+, 168.6 ± 7.2%;
K+ + isradipine, 141.3 ± 9.7%; K+ +
-Ctx GVIA +
-Agatx IVA, 119.6 ± 15.7%; K+ +
-Ctx GVIA +
-Agatx IVA + isradipine, 136.4 ± 21.5%; n = 5], suggesting that blockade of the L-type
Ca2+ channel had no significant effect.
BAY K 8644 (106 M), which selectively activates L-type
channels, failed to significantly stimulate either basal or
K+-induced VIP release, respectively [basal, 149.8 ± 32.9 pg/mg (100%); BAY K 8644, 98.6 ± 20.8%; K+,
166.7 ± 18.4%; K+ + BAY K 8644, 134.8 ± 24.9%; n = 4].
Low-threshold T-type Ca2+ channels and
high-threshold R-type Ca2+ channels are sensitive to
blockade by Ni2+. Addition of Ni2+
(106-10
4 M) had no significant effect
on synaptosomal VIP release evoked by K+ [basal,
217.1 ± 3.3 pg/mg (100%); K+, 134.0 ± 4.3%;
10
6 M Ni2+, 125.3 ± 26.6%;
10
5 M Ni2+, 159.1 ± 34.9%;
10
4 M Ni2+, 141.9 ± 30.9%;
n = 3].
Since the synaptosomal fraction consists of a mixed population of
enteric nerves, which could release their neurotransmitter in response
to K+ depolarization, the observed effect of the VDCCs
could be due to an indirect action on other nerve terminals than the
VIPergic one. To clarify this, we investigated whether carbachol,
substance P, or the opioid peptides had a stimulatory effect on VIP
release from nerve terminals. The respective data are shown in Table
1.
|
Effect of Subtype-Specific Ca2+ Channel Blockers on NOS Activity in Enteric Synaptosomes
NOS activity (in fmol · mg
|
These data suggest that, with respect to NO synthesis, not only P- and
N- type channels but also L-type channels are involved, whereas Q- and
T-type channels are presumably of minor relevance. Since in the central
nervous system NMDA receptor activation induces Ca2+
influx, thereby stimulating NOS, the effect of both NMDA receptor stimulation and blockade was studied. Addition of NMDA or glutamate does not alter cofactor-stimulated NOS activity (control, 2.2 ± 0.1; 107 M NMDA, 2.0 ± 0.3; 10
6 M
NMDA, 1.9 ± 0.3; 10
5 M NMDA, 1.8 ± 0.4;
10
7 M glutamate, 2.1 ± 0.3; 10
6 M
glutamate, 2.0 ± 0.3; 10
5 M glutamate, 1.9 ± 0.2; no treatment was significant vs. control; n = 5).
The NMDA receptor antagonist R-4-carboxy-3-hydroxyphenylglycine also
did not modify NOS activity (control, 2.2 ± 0.1;
10
6 M R-4-carboxy-3-hydroxyphenyl-glycine, 2.0 ± 0.3; not significant vs. control; n = 4). Similar
results were obtained with ACBC, an NMDA receptor antagonist at the
glycine site (control, 2.2 ± 0.1; 10
6 M ACBC,
2.9 ± 1.1; not significant vs. control; n = 4).
Since addition of Ca2+ evokes the release of other
neurotransmitters, which in turn might stimulate NO production in
synaptosomes, a new series of experiments was conducted. The data
obtained with carbachol, substance P, and the respective agonists at
the opioid µ-, -, and
-receptors, endomorphin-1, DPDPE, and
U-50488 are shown in Table 2.
|
Effect of Subtype-Specific Ca2+-Channel Blockers on VIP Release by Exogenous NO
SNAP induced a significant release of VIP, which was blocked in the presence of the NO scavenger oxyhemoglobin (basal, 100%; 10Since the foregoing data suggest the presence of N- and P-type Ca2+ channels on enteric synaptosomes and their functional relation to VIP secretion, another series of experiments was conducted to inquire about the role of VDCCs in VIP release under the conditions employed with exogenous NO.
In Ca2+-free medium containing 0.5 M EGTA, NO-induced
VIP release was not significantly reduced [basal, 135.2 ± 26.2 pg/mg (100%); 104 M SNAP, 160.4 ± 15.1%;
SNAP/Ca2+-free medium, 131.2 ± 27.9%;
n = 6]. Accordingly, neither treatment with any
subtype-selective Ca2+ channel blocker was able to
significantly antagonize NO-induced VIP release [basal, 168.0 ± 24.7 pg/mg (100%); 10
4 M SNAP, 149.4 ± 11.4%;
SNAP + 10
6 M
-Ctx GVIA, 153.1 ± 12.4%;
SNAP + 3 × 10
8 M
-Agatx IVA, 150.6 ± 12.5%; SNAP +
-Agatx IVA +
-Ctx GVIA, 162.2 ± 25.6%; SNAP + isradipine, 142.4 ± 10.9%; SNAP +
-Ctx MVIIC, 163.6 ± 27.7%; SNAP + Ni2+,
180.4 ± 42.2%; n = 7]. An additional series of
experiments with the NO donor DEA-NO (10
6 M), a NONOate,
confirmed the previous data obtained with SNAP (data not shown).
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
NANC relaxation of gastrointestinal muscle is mediated by NO and
VIP, both of which are localized in descending inhibitory interneurons
of the enteric nervous system. With respect to smooth muscle
relaxation, interaction between these two transmitters appears to be
likely; however, it is hard to assess since the enteric nervous system
is a complex system and interference of local or systemic factors
cannot be ruled out in vivo or in the intact organ in vitro. As an
alternative approach, we used a synaptosomal preparation to inquire
about the subcellular mechanisms involved in the release of VIP and NO
synthesis. With respect to VIP release, previous data from enteric
nerve terminals (3) and from isolated ganglia
(21) could be confirmed showing that K+ is
capable stimulating VIP release Ca2+ dependently. NO
synthesis also strictly requires Ca2+ (23).
Additionally, it could be shown that within isolated enteric nerve
terminals NO synthesis is both coupled to VIP release (29)
and under feedback control of endogenous or exogenous NO (30). There is evidence that NO-mediated relaxation of
intestinal smooth muscle is strongly dependent on Ca2+
entry through N-type Ca2+ channels, which are blocked
specifically by -Ctx GVIA (7, 11, 13). Accordingly,
experiments were performed to investigate the role of different VDCCs
in the release of VIP and NO synthesis in enteric synaptosomes.
Immunohistochemistry revealed the presence of the
1A-
and
1B-subunits corresponding to the P- and N-type Ca2+ channels as well as the
1C- and
1D-subunits corresponding to the L-type Ca2+
channel in the enteric nervous system, respectively (26).
The data presented here clearly indicate that, following K+
depolarization, N- and P-type Ca2+ channels are apparently
coupled to VIP release, which extends previous findings in LM/MP
preparations (13). Basal VIP output presumably is under
control of the P-type Ca2+ channel. However, the
synaptosomal fraction contains a mixed population of nerve endings,
releasing their respective neurotransmitters in the presence of
depolarizing stimuli. Assuming that some of these nerve endings
synthesize a transmitter that stimulates VIP release, it could be
speculated that the VDCCs might act indirectly and not at VIPergic
nerve terminals. In another series of experiments, we inquired about a
possible effect of other transmitters on VIP release. The "chemical
coding" of the rat gut is quite different from other species
(18). Inhibitory motor neurons contain almost exclusively
NOS and/or VIP. The transmitters of excitatory motor neurons are
acetylcholine, substance P, and/or opioid peptides, whereas the
secretomotor neurons contain either VIP or substance P
(18). Other peptidergic transmitters, detected by
immunohistochemistry in the rat enteric nervous system, like
somatostatin, neuromedin U, neurotensin, and CGRP, are almost
exclusively confined to enteric ganglia. Within nerve fibers supplying
the smooth muscle, they are observed in small numbers only
(16). Enteric ganglia, however, are separated by the means
of differential centrifugation during the preparation of synaptosomes
(28). With respect to recently published functional data
showing that both galanin and neuropeptide Y, which are present in
moderate numbers within nerve fibers to smooth muscle
(16), inhibit VIP output from the LM/MP preparation (12), the transmitters substance P, acetylcholine, and
opioid peptides appeared to be the most likely candidates to stimulate VIP release. Our data show that none of the latter transmitters has a
stimulatory effect on VIP release, suggesting that the VDCCs are acting
directly on VIPergic nerves.
A second series of experiments was conducted to investigate the role of Ca2+ channels in NO production. Our data confirmed and extended previous findings (13) showing that not only N-type but also L-type and P-type Ca2+ channels provide Ca2+ influx into the nerve terminal to enable NO production. In analogy to the VIP assay, we investigated whether the effect is due to an indirect modulatory effect of VDCCs on nerve terminals containing either substance P, acetylcholine, or opioid peptides, which in turn could stimulate NO production. The latter substances did not modify NOS activity, suggesting a direct modulatory effect of the VDCCs on NOS-containing neurons.
Interestingly, NO biosynthesis in the brain is regulated by NMDA receptor-activated Ca2+ influx (19, 20). In enteric synaptosomes, both NMDA/glutamate and the NMDA receptor antagonists failed to influence NO synthesis significantly. These results indicate that distinct Ca2+ influx pathways specifically regulate nNOS activity in various tissues.
Further experiments were conducted to clarify the role of VDCCs in NO-mediated VIP release. In contrast to depolarization-induced VIP release, the NO-induced VIP secretion was not blocked in the presence of Ca2+ channel blockers. There is cumulative evidence that NO triggers exocytosis by bypassing requirements of Ca2+ influx (33, 40). NO could accordingly release VIP in different ways, interacting with the release machinery (32), modulating ion channels on the membrane (27), or activating intracellular signal transduction systems (42). The last of these has been demonstrated for NO-induced VIP release from enteric synaptosomes, since it could be antagonized in the presence of blockers of the cGMP/protein kinase G pathway (29). Previous studies in the central nervous system have shown that cGMP analogs and NO donors reduce synaptosomal [Ca2+]i (33), which appears to be incompatible with the generally accepted Ca2+ requirement for exocytosis. Our data support the notion that VIP release, although normally highly Ca2+-dependent, might occur in a Ca2+-independent manner. Further experiments are needed to clarify the exact mechanism involved.
From the data presented, clear evidence could be obtained that the
suppression of NO-mediated intestinal relaxation by the N-type
Ca2+ channel antagonist -Ctx GVIA (6, 13)
is presumably not due to inhibition of NO-induced VIP release. The data
also show that NO production and VIP release by depolarizing stimuli
are differentially regulated with respect to the involvement of L-type channels. The functional role of these L-type channels in NO synthesis needs to be clarified. The L-type channel is encoded by the
1C- and
1D-subunits. The presence of both
1C- and
1D-subunits in enteric nerve
terminals had been demonstrated by immunochemistry (26).
L-type channels apparently are involved in neurotransmitter release
from cerebellar synapses (36), NANC nerves supplying the iris muscle (24), and dendrites of hippocampal
granule cells (39), but its involvement in the
release process of neuropeptides in the enteric nervous system has
not yet been established. Another concept for the functional role
of L-type channels in neuronal tissue is provided by studies in
hippocampal neurons. It could be shown that mobilization of
calmodulin from cytosolic sources can be induced by certain
Ca2+ entry systems, like L-type channels or NMDA receptors,
but not by N- or P-type channels (14). Since
binding of calmodulin to NOS is prerequisite for NO
production and nNOS itself is targeted to specific
intraterminal regions (10), the mobilization of calmodulin could be functionally related to the L-type channel. However, this is speculative and deserves further elucidation.
In conclusion, we demonstrated that VIP release following K+ depolarization is coupled to N- and P-type Ca2+ channels, whereas NO synthesis is presumably dependent on Ca2+ influx via the N-, P-, and L-type Ca2+ channels. However, VDCCs appear not to be functionally coupled to the VIP release in response to extracellular NO, implying the possibility that intracellular Ca2+ stores, for example of mitochondrial origin, are of central importance for an interplay between the two messenger substances NO and Ca2+.
![]() |
ACKNOWLEDGEMENTS |
---|
We acknowledge the cooperation of Prof. Dr. F. Hofmann, Department of Pharmacology, Prof. Dr. B. Gänsbacher, Prof. Dr. W. Erhardt, and their collaborators, Department of Experimental Surgery, Technical University of Munich. We also thank Heidi Paeghe and Sabine Herda for their expert technical assistance.
![]() |
FOOTNOTES |
---|
This study was supported by Deutsche Forschungsgemeinschaft (SFB 391/C5).
Parts of this work have been presented in abstract form at the annual meeting of the American Gastroenterological Association (New Orleans, 1998).
Address for reprint requests and other correspondence: M. Kurjak, Dept. of Internal Medicine II, Technical Univ. of Munich, Ismaninger Str. 22, 81675 Munich, Germany (E-mail: manfred.kurjak{at}lrz.tu-muenchen.de).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
July 31, 2002;10.1152/ajpgi.00400.2001
Received 11 September 2001; accepted in final form 23 July 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Ahmad, S,
Rausa J,
Jang E,
and
Daniel EE.
Calcium channel binding in nerves and muscle of canine small intestine.
Biochem Biophys Res Commun
159:
119-125,
1989[ISI][Medline].
2.
Aimi, Y,
Kimura H,
Kinoshita T,
Minami Y,
Fujimura M,
and
Vincent SR.
Histochemical localization of nitric oxide synthase in rat enteric nervous system.
Neuroscience
53:
553-560,
1993[ISI][Medline].
3.
Allescher, HD,
Kurjak M,
Huber A,
Trudrung P,
and
Schusdziarra V.
Regulation of VIP release from rat enteric nerve terminals: evidence for a stimulatory effect of NO.
Am J Physiol Gastrointest Liver Physiol
271:
G568-G574,
1996
4.
Bennett, MK.
Ca2+ and the regulation of neurotransmitter secretion.
Curr Opin Neurol
7:
316-322,
1997.
5.
Berezin, I,
Snyder SH,
Bredt DS,
and
Daniel EE.
Ultrastructural localization of nitric oxide synthase in canine small intestine and colon.
Am J Physiol Cell Physiol
266:
C981-C989,
1994
6.
Boeckxstaens, GE,
De Man JG,
Pelckmans PA,
Cromheeke KM,
Herman AG,
and
Van Maercke YM.
Ca2+ dependency of the release of nitric oxide from non-adrenergic, non-cholinergic nerves.
Br J Pharmacol
110:
1329-1334,
1993[Abstract].
7.
Borderies, JR,
Gonalons E,
Angel F,
Vergara P,
and
Jimenez M.
Effect of different calcium channel blockers on inhibitory junction potentials and slow waves in porcine ileum.
Life Sci
60:
883-892,
1997[ISI][Medline].
8.
Bradford, M.
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding.
Anal Biochem
72:
248-254,
1976[ISI][Medline].
9.
Bredt, DS,
and
Synder SH.
Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
Proc Natl Acad Sci USA
86:
9030-9033,
1989[Abstract].
10.
Brenman, JE,
Chao DS,
Xia H,
Aldabe K,
and
Bredt DS.
Nitric oxide synthase is complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.
Cell
82:
743-752,
1995[ISI][Medline].
11.
Cayabyab, FS,
de Bruin H,
Jiménez M,
and
Daniel EE.
Ca2+ role in myogenic and neurogenic activities of canine ileum circular muscle.
Am J Physiol Gastrointest Liver Physiol
271:
G1053-G1066,
1996
12.
Daniel, EE,
and
Fox-Threlkeld JET
VIP release from small intestinal neurons: its modulation by multiple neuropeptides; association with motility changes and functional role.
Biomed Res (Tokyo)
13:
195-200,
1992[ISI].
13.
Daniel, EE,
Haugh C,
Woskowska Z,
Cipris S,
Jury J,
and
Fox-Threlkeld JET
Role of nitric oxide-related inhibition in intestinal function: relation to vasoactive intestinal polypeptide.
Am J Physiol Gastrointest Liver Physiol
266:
G31-G39,
1994
14.
Deisseroth, K,
Heist EK,
and
Tsien RW.
Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons.
Nature
392:
198-202,
1998[ISI][Medline].
15.
Dunlap, KLJI,
and
Turner TJ.
Exocytotic Ca2+ channels in mammalian central neurons.
Trends Neurosci
18:
89-98,
1995[ISI][Medline].
16.
Ekblad, E,
Hakanson R,
and
Sundler S.
Microanatomy and chemical coding of peptide containing neurons in the digestive tract.
In: Neuropeptide Function in the Gastrointestinal Tract, edited by Daniel EE.. Boca Raton, FL: CRC, 1991, p. 139-179.
17.
Ekblad, E,
Mulder H,
Uddman R,
and
Sundler F.
NOS-containing neurons in the rat gut and coeliac ganglia.
Neuropharmacology
33:
1323-1331,
1994[ISI][Medline].
18.
Furness, JB,
Young HM,
Pompolo S,
Bornstein JC,
Kunze WAA,
and
McConalogue K.
Plurichemical transmission and chemical coding of neurons in the digestive tract.
Gastroenterology
108:
554-563,
1995[ISI][Medline].
19.
Garthwaite, J,
and
Boulton CL.
Nitric oxide signaling in the central nervous system.
Annu Rev Physiol
57:
683-706,
1995[ISI][Medline].
20.
Garthwaite, J,
Charles SL,
and
Chess-Williams R.
Endothelium-derived relaxing factor release on activation of NMDA receptors suggests its role as intracellular messenger in the brain.
Nature
336:
385-388,
1988[ISI][Medline].
21.
Grider, JR,
and
Jin JG.
Vasoactive intestinal peptide release and L-citrulline production from isolated ganglia of the myenteric plexus: evidence for regulation of vasoactive intestinal peptide release by nitric oxide.
Neuroscience
54:
521-526,
1993[ISI][Medline].
22.
Hofmann, F,
Biel M,
and
Flockerzi V.
Molecular basis for Ca2+ channel diversity.
Annu Rev Neurosci
17:
399-418,
1994[ISI][Medline].
23.
Huber, A,
Saur D,
Kurjak M,
Schusdziarra V,
and
Allescher HD.
Characterization and splice variants of neuronal nitric oxide synthase in rat small intestine.
Am J Physiol Gastrointest Liver Physiol
275:
G1146-G1156,
1998
24.
Kageyama, M,
Fujita H,
Nakata K,
and
Shirasawa E.
Involvement of both L- and N-type voltage-dependent Ca2+ channels in KCl- and veratridine-evoked transmitter release from non-adrenergic, non-cholinergic nerves in the rabbit iris sphincter muscle.
Naunyn Schmiedebergs Arch Pharmacol
355:
638-644,
1997[Medline].
25.
Katz, B.
The Croonian Lecture: the transmission of impulses from nerve to muscle and the subcellular unit of synaptic action.
Proc R Soc
155:
455-477,
1962[ISI].
26.
Kirchgessner, AL,
and
Liu M.
Differential localization of Ca2+ channel alpha1 subunits in the enteric nervous system: presence of alpha1B channel-like immunoreactivity in intrinsic primary afferent neurons.
J Comp Neurol
409:
85-104,
1999[ISI][Medline].
27.
Kurenny, DE,
Moroz LL,
Turner RW,
Sharkey KA,
and
Barnes S.
Modulation of ion channels in rod photoreceptors by nitric oxide.
Neuron
13:
315-324,
1994[ISI][Medline].
28.
Kurjak, M,
Allescher HD,
Schusdziarra V,
and
Classen M.
Release of bombesin-like immunoreactivity from synaptosomes isolated from the rat ileum.
Eur J Pharmacol
257:
169-179,
1994[ISI][Medline].
29.
Kurjak, M,
Fritsch R,
Saur D,
Schusdziarra V,
and
Allescher HD.
Functional coupling between nitric oxide synthesis and VIP release within enteric nerve terminals of the rat: involvement of protein kinase G and phosphodiesterase 5.
J Physiol
534:
827-836,
2001
30.
Kurjak, M,
Koppitz P,
Schusdziarra V,
and
Allescher HD.
Evidence for a feedback inhibition of NO synthesis in enteric synaptosomes via a nitrosothiol-intermediate.
Am J Physiol Gastrointest Liver Physiol
277:
G875-G884,
1999
31.
Lundy, PM,
and
Frew R.
Review: Ca2+ channel subtypes in peripheral efferent autonomic nerves.
J Auton Pharmacol
16:
229-241,
1996[ISI][Medline].
32.
Meffert, MK,
Calakos NC,
Scheller RH,
and
Schulman H.
Nitric oxide modulates synaptic vesicle docking/fusion reactions.
Neuron
16:
1229-1236,
1996[ISI][Medline].
33.
Meffert, MK,
Premack BA,
and
Schulman H.
Nitric oxide stimulates Ca2+-independent synaptic vesicle release.
Neuron
12:
1235-1244,
1994[ISI][Medline].
34.
Meir, A,
Ginsburg S,
Butkevich A,
Kachalsky SG,
Kaiserman I,
Ahdut R,
Demirgoren S,
and
Rahamimoff R.
Ion channels in presynaptic nerve terminals and control of transmitter release.
Physiol Rev
79:
1019-1088,
1999
35.
Mitchell, SJ,
and
Bloom SR.
Measurement of fasting and postprandial plasma VIP in man.
Gut
19:
1043-1048,
1978[Abstract].
36.
Momiyama, A,
and
Takahashi T.
Calcium channels responsible for potassium-induced transmitter release at rat cerebellar synapses.
J Physiol
476:
197-202,
1994[Abstract].
37.
Reis, HJ,
Massensini AR,
Prado MAM,
Gomez RS,
Gomez MV,
and
Romano-Silva MA.
Calcium channels coupled to depolarization-evoked glutamate release in the myenteric plexus of guinea-pig ileum.
Neuroscience
101:
237-242,
2000[ISI][Medline].
38.
Reuter, H.
Diversity and function of presynaptic calcium channels in the brain.
Curr Opin Neurobiol
6:
331-337,
1996[ISI][Medline].
39.
Simmons, ML,
Terman GW,
Gibbs SM,
and
Chavkin C.
L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells.
Neuron
14:
1265-1272,
1995[ISI][Medline].
40.
Sporns, O,
and
Jenkinson S.
Potassium ion- and nitric oxide-induced exocytosis from populations of hippocampal synapses during synaptic maturation.
Neuroscience
80:
1057-1073,
1997[ISI][Medline].
41.
Starodub, AM,
and
Wood JD.
Selectivity of omega-CgTx-MVIIC toxin from conus magus on calcium currents in enteric neurons.
Life Sci
64:
PL305-PL310,
1999[ISI][Medline].
42.
Wang, X,
and
Robinson PJ.
Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system.
J Neurochem
68:
443-456,
1997[ISI][Medline].
43.
Wessler, I,
Dooley DJ,
Werhand J,
and
Schlemmer F.
Differential effects of calcium channel antagonists (omega-conotoxin GVIA, nifedipine, verapamil) on the electrically-evoked release of (3H)acetylcholine from the myenteric plexus, phrenic nerve and neocortex of rats.
Naunyn Schmiedebergs Arch Pharmacol
341:
288-294,
1990[ISI][Medline].